Differences in stroke outcome based on sex

Objective: Stroke thrombolysis may have a differential effect by sex. We sought to examine the relationship between sex and outcome after thrombolysis. Methods: This is a retrospective cohort study of stroke patients from the Registry of Canadian Stroke Network phase 1 (June 2001-February 2002) and phase 2 (June 2002-December 2002). Variables including demographics, history, clinical data, process measures, and outcome were analyzed. The primary outcomes were the Stroke Impact Scale-16 score (SIS-16) and mortality at 6 months. We compared the outcomes of the thrombolyzed and nonthrombolyzed cohorts and examined the data for a tissue plasminogen activator (tPA)-by-sex interaction on the 2 primary outcomes. Results: The overall proportion of patients who achieved an excellent outcome (SIS-16 >75) was not different by gender. However, the proportion of patients achieving an excellent outcome in the non-tPA cohort was much greater in males, with an absolute risk difference of 11.8%. A multiplicative treatment by sex interaction was evident (p = 0.054). This interaction was not present for stroke case fatality. Conclusions: Women fared poorly compared to men in the placebo groups, but this negative prognostic sex effect was neutralized by thrombolysis.

[1]  L. Wilkins Differences in stroke outcome based on sex , 2010, Neurology.

[2]  R. Nardin RANDOMIZED, CONTROLLED TRIAL OF TELCAGEPANT FOR THE ACUTE TREATMENT OF MIGRAINE , 2010, Neurology.

[3]  A. Hakim,et al.  Pre Admission Antithrombotics are Associated with Improved Outcomes following Ischaemic Stroke: A Cohort from the Registry of the Canadian Stroke Network , 2009, International journal of stroke : official journal of the International Stroke Society.

[4]  N. Sethi EXCESSIVE ACUTE MIGRAINE MEDICATION USE AND MIGRAINE PROGRESSION , 2009, Neurology.

[5]  R. Lipton,et al.  The Acute Treatment of Episodic and Chronic Migraine in the USA , 2009, Cephalalgia : an international journal of headache.

[6]  S. Tepper,et al.  Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine. , 2009, Current opinion in investigational drugs.

[7]  S. Söderberg,et al.  Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[8]  George Howard,et al.  Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes , 2008, The Lancet Neurology.

[9]  D. Kent,et al.  The gender effect in stroke thrombolysis , 2008, Neurology.

[10]  Sumit R. Majumdar,et al.  Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis , 2008, Diabetes Care.

[11]  M. Lynn,et al.  Gender Differences in Outcomes Among Patients With Symptomatic Intracranial Arterial Stenosis , 2007, Stroke.

[12]  T. Neumann-Haefelin,et al.  Sex Disparity in the Access of Elderly Patients to Acute Stroke Care , 2007, Stroke.

[13]  W. Koroshetz,et al.  Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke , 2007, Neurology.

[14]  D. Kent,et al.  Sex-Based Differences in the Effect of Intra-Arterial Treatment of Stroke: Analysis of the PROACT-2 Study , 2006, Stroke.

[15]  P. Vespa,et al.  Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke , 2006, Neurology.

[16]  D. Kent,et al.  Gender differences in tPA-related arterial recanalization. , 2005, Stroke.

[17]  V. Hachinski,et al.  Predictors of major neurologic improvement after thrombolysis in acute stroke , 2005, Neurology.

[18]  G. Schlaug,et al.  Arterial Occlusive Lesions Recanalize More Frequently in Women Than in Men After Intravenous Tissue Plasminogen Activator Administration for Acute Stroke , 2005, Stroke.

[19]  F. Silver,et al.  Sex Differences in Stroke Care and Outcomes: Results From the Registry of the Canadian Stroke Network , 2005, Stroke.

[20]  L. Price,et al.  Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Pooled Analysis of Randomized Clinical Trials , 2005, Stroke.

[21]  Jack V Tu,et al.  Impracticability of informed consent in the Registry of the Canadian Stroke Network. , 2004, The New England journal of medicine.

[22]  J. Arenillas,et al.  Differential Pattern of Tissue Plasminogen Activator–Induced Proximal Middle Cerebral Artery Recanalization Among Stroke Subtypes , 2004, Stroke.

[23]  B. Edwards,et al.  Internal consistency and validity of the Stroke Impact Scale 2.0 (SIS 2.0) and SIS-16 in an Australian sample , 2003, Quality of Life Research.

[24]  M. Paoli,et al.  Cardiovascular Risk of Young Growth-Hormone-Deficient Adolescents , 2003, Hormone Research in Paediatrics.

[25]  P. Austin,et al.  Sex Differences in Carotid Endarterectomy Outcomes: Results From the Ontario Carotid Endarterectomy Registry , 2003, Stroke.

[26]  A. Carter,et al.  Gender differences in coagulation and fibrinolysis in white subjects with acute ischemic stroke , 2003, Journal of thrombosis and haemostasis : JTH.

[27]  S. Perera,et al.  Stroke Impact Scale-16 , 2003, Neurology.

[28]  D. Mccrory,et al.  Oral sumatriptan for acute migraine. , 2003, The Cochrane database of systematic reviews.

[29]  A. Carter,et al.  Decreased fibrinolytic potential in South Asian women with ischaemic cerebrovascular disease , 2001, British Journal of Haematology.

[30]  T. Murohara,et al.  Hypercholesterolemia Inhibits Angiogenesis in Response to Hindlimb Ischemia: Nitric Oxide–Dependent Mechanism , 2000, Circulation.

[31]  S. Paradiso,et al.  Gender differences in poststroke depression. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[32]  Sumon YusufPhotoshare Care , 1890, The Hospital.